Literature DB >> 7604983

Phenotype of dystrophinopathy in old mdx mice.

J P Lefaucheur1, C Pastoret, A Sebille.   

Abstract

BACKGROUND: Mdx mutant mice, like patients with Duchenne Muscular Dystrophy (DMD), lack dystrophin, a subsarcolemmal protein, that results in myofiber necrosis. However young mdx mice, in contrast to DMD children, exhibit a successful muscle regeneration and not an extensive fibrosis.
METHODS: Old mdx mice were monitored clinically up to their spontaneous death, and most of their organs were studied histologically to look for differences with those of the wild C57BL/10 mice strain.
RESULTS: In old mdx mice (at least 20 months of age), we report clinical and pathological features of muscular dystrophy, i.e., progressive motor weakness and loss of myofibers replaced by extensive connective tissue, similar to the phenotype of dystrophinopathy observed in DMD patients. Various degrees of dystrophic involvement were observed in cardiac, respiratory, postural, and hindlimb skeletal mdx muscles and also in smooth muscles of the digestive and urinary tracts. No gross histological abnormalities were found in other tissue than muscular tissue.
CONCLUSIONS: Late in life, mdx mice develop a muscular dystrophy close to DMD dystrophinopathy. We suggest that the study of the effects of ageing in mdx mice would give clues to better understand the pathophysiology of DMD.

Entities:  

Mesh:

Year:  1995        PMID: 7604983     DOI: 10.1002/ar.1092420109

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  60 in total

1.  Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.

Authors:  G S Lynch; R T Hinkle; J S Chamberlain; S V Brooks; J A Faulkner
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

2.  Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration.

Authors:  Robyn Meech; Katie N Gonzalez; Marietta Barro; Anastasia Gromova; Lizhe Zhuang; Julie-Ann Hulin; Helen P Makarenkova
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

3.  TRPC3 channels confer cellular memory of recent neuromuscular activity.

Authors:  Paul Rosenberg; April Hawkins; Jonathan Stiber; John M Shelton; Kelley Hutcheson; Rhonda Bassel-Duby; Dong Min Shin; Zhen Yan; R Sanders Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

4.  β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.

Authors:  Jianming Liu; Derek J Milner; Marni D Boppart; Robert S Ross; Stephen J Kaufman
Journal:  Hum Mol Genet       Date:  2011-12-16       Impact factor: 6.150

5.  Ventilation during air breathing and in response to hypercapnia in 5 and 16 month-old mdx and C57 mice.

Authors:  Jerome Gayraud; Stefan Matecki; Karim Hnia; Dominique Mornet; Christian Prefaut; Jacques Mercier; Alain Michel; Michele Ramonatxo
Journal:  J Muscle Res Cell Motil       Date:  2007-04-13       Impact factor: 2.698

6.  AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice.

Authors:  Brian Bostick; Jin-Hong Shin; Yongping Yue; Dongsheng Duan
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

Review 7.  Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy.

Authors:  Dominic J Wells
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

8.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

9.  Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice.

Authors:  Chady H Hakim; Dongsheng Duan
Journal:  J Appl Physiol (1985)       Date:  2012-12-06

Review 10.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.